Bicycle Therapeutics plc (BCYC)

SEC filing

Bicycle Therapeutics plc

BCYC · CIK 1761612

4 · Oct 6, 2026 · Chief Financial Officer Thompson Travis Alvin sold 972 shares at $3.48/share ($3,381)

Chief Financial Officer Thompson Travis Alvin sold 972 shares at $3.48/share ($3,381)

xslF345X06/form4-10062026_081052.xml

xslF345X06/form4-10062026_081052.xmlSEC.gov

Graphics and non-inline formats (not embedded below).